Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 96

    1.

    Challenges in studying the etiology of breast cancer subtypes.

    Troester MA, Swift-Scanlan T.

    Breast Cancer Res. 2009;11(3):104. Epub 2009 Jun 29.

    PMID:
    19635173
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms.

    Sørlie T, Wang Y, Xiao C, Johnsen H, Naume B, Samaha RR, Børresen-Dale AL.

    BMC Genomics. 2006 May 26;7:127.

    PMID:
    16729877
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    3.

    Clinical significance of basal-like subtype in triple-negative breast cancer.

    Yamamoto Y, Ibusuki M, Nakano M, Kawasoe T, Hiki R, Iwase H.

    Breast Cancer. 2009;16(4):260-7. Epub 2009 Aug 22.

    PMID:
    19701681
    [PubMed - indexed for MEDLINE]
    5.

    Challenges in projecting clustering results across gene expression-profiling datasets.

    Lusa L, McShane LM, Reid JF, De Cecco L, Ambrogi F, Biganzoli E, Gariboldi M, Pierotti MA.

    J Natl Cancer Inst. 2007 Nov 21;99(22):1715-23. Epub 2007 Nov 13.

    PMID:
    18000217
    [PubMed - indexed for MEDLINE]
    Free Article
    6.

    Triple-negative breast cancer.

    Stockmans G, Deraedt K, Wildiers H, Moerman P, Paridaens R.

    Curr Opin Oncol. 2008 Nov;20(6):614-20. Review.

    PMID:
    18841042
    [PubMed - indexed for MEDLINE]
    7.

    Molecular breast cancer subtypes in premenopausal and postmenopausal African-American women: age-specific prevalence and survival.

    Ihemelandu CU, Leffall LD Jr, Dewitty RL, Naab TJ, Mezghebe HM, Makambi KH, Adams-Campbell L, Frederick WA.

    J Surg Res. 2007 Nov;143(1):109-18.

    PMID:
    17950079
    [PubMed - indexed for MEDLINE]
    8.

    Triple-negative/basal-like breast cancer: review.

    Rakha EA, Ellis IO.

    Pathology. 2009 Jan;41(1):40-7. Review.

    PMID:
    19089739
    [PubMed - indexed for MEDLINE]
    9.

    What is triple-negative breast cancer?

    Irvin WJ Jr, Carey LA.

    Eur J Cancer. 2008 Dec;44(18):2799-805. Epub 2008 Nov 12. Review.

    PMID:
    19008097
    [PubMed - indexed for MEDLINE]
    10.

    Identification of cell-of-origin breast tumor subtypes in inflammatory breast cancer by gene expression profiling.

    Van Laere SJ, Van den Eynden GG, Van der Auwera I, Vandenberghe M, van Dam P, Van Marck EA, van Golen KL, Vermeulen PB, Dirix LY.

    Breast Cancer Res Treat. 2006 Feb;95(3):243-55. Epub 2005 Oct 27.

    PMID:
    16261404
    [PubMed - indexed for MEDLINE]
    11.

    Triple negative tumours: a critical review.

    Reis-Filho JS, Tutt AN.

    Histopathology. 2008 Jan;52(1):108-18. Review.

    PMID:
    18171422
    [PubMed - indexed for MEDLINE]
    12.

    Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes.

    Habibi G, Leung S, Law JH, Gelmon K, Masoudi H, Turbin D, Pollak M, Nielsen TO, Huntsman D, Dunn SE.

    Breast Cancer Res. 2008;10(5):R86. Epub 2008 Oct 16.

    PMID:
    18925950
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    13.

    Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype.

    Cheang MC, Voduc D, Bajdik C, Leung S, McKinney S, Chia SK, Perou CM, Nielsen TO.

    Clin Cancer Res. 2008 Mar 1;14(5):1368-76.

    PMID:
    18316557
    [PubMed - indexed for MEDLINE]
    Free Article
    14.

    Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors.

    Kwan ML, Kushi LH, Weltzien E, Maring B, Kutner SE, Fulton RS, Lee MM, Ambrosone CB, Caan BJ.

    Breast Cancer Res. 2009;11(3):R31. Epub 2009 May 22.

    PMID:
    19463150
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    15.

    Conservation of breast cancer molecular subtypes and transcriptional patterns of tumor progression across distinct ethnic populations.

    Yu K, Lee CH, Tan PH, Tan P.

    Clin Cancer Res. 2004 Aug 15;10(16):5508-17.

    PMID:
    15328190
    [PubMed - indexed for MEDLINE]
    Free Article
    16.

    Differences in risk factors for breast cancer molecular subtypes in a population-based study.

    Yang XR, Sherman ME, Rimm DL, Lissowska J, Brinton LA, Peplonska B, Hewitt SM, Anderson WF, Szeszenia-Dabrowska N, Bardin-Mikolajczak A, Zatonski W, Cartun R, Mandich D, Rymkiewicz G, Ligaj M, Lukaszek S, Kordek R, García-Closas M.

    Cancer Epidemiol Biomarkers Prev. 2007 Mar;16(3):439-43.

    PMID:
    17372238
    [PubMed - indexed for MEDLINE]
    Free Article
    17.

    Reproductive and hormonal risk factors for postmenopausal luminal, HER-2-overexpressing, and triple-negative breast cancer.

    Phipps AI, Malone KE, Porter PL, Daling JR, Li CI.

    Cancer. 2008 Oct 1;113(7):1521-6.

    PMID:
    18726992
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    18.

    Possible treatment strategies for triple-negative breast cancer on the basis of molecular characteristics.

    Kurebayashi J.

    Breast Cancer. 2009;16(4):275-80. Epub 2009 May 1.

    PMID:
    19408071
    [PubMed - indexed for MEDLINE]
    19.

    Triple negative breast carcinoma and the basal phenotype: from expression profiling to clinical practice.

    Diaz LK, Cryns VL, Symmans WF, Sneige N.

    Adv Anat Pathol. 2007 Nov;14(6):419-30. Review.

    PMID:
    18049131
    [PubMed - indexed for MEDLINE]
    20.

    Triple-negative breast cancer: distinguishing between basal and nonbasal subtypes.

    Rakha EA, Elsheikh SE, Aleskandarany MA, Habashi HO, Green AR, Powe DG, El-Sayed ME, Benhasouna A, Brunet JS, Akslen LA, Evans AJ, Blamey R, Reis-Filho JS, Foulkes WD, Ellis IO.

    Clin Cancer Res. 2009 Apr 1;15(7):2302-10. Epub 2009 Mar 24.

    PMID:
    19318481
    [PubMed - indexed for MEDLINE]
    Free Article

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk